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Thyrotropin-Releasing Hormone Selectively
Stimulates Human Hair Follicle Pigmentation
Erzse´bet Ga´spa´r1,5,6, Kim T. Nguyen-Thi1,5, Celine Hardenbicker1, Stephan Tiede1, Christian Plate1,
Enik +o Bodo´1,7, Jana Knuever1, Wolfgang Funk2, Tama´s Bı´ro´3 and Ralf Paus1,4
In amphibians, thyrotropin-releasing hormone (TRH) stimulates skin melanophores by inducing secretion of
a-melanocyte-stimulating hormone in the pituitary gland. However, it is unknown whether this tripeptide
neurohormone exerts any direct effects on pigment cells, namely, on human melanocytes, under physiological
conditions. Therefore, we have investigated whether TRH stimulates pigment production in organ-cultured
human hair follicles (HFs), the epithelium of which expresses both TRH and its receptor, and/or in full-thickness
human skin in situ. TRH stimulated melanin synthesis, tyrosinase transcription and activity, melanosome
formation, melanocyte dendricity, gp100 immunoreactivity, and microphthalmia-associated transcription factor
expression in human HFs in a pituitary gland-independent manner. TRH also stimulated proliferation, gp100
expression, tyrosinase activity, and dendricity of isolated human HF melanocytes. However, intraepidermal
melanogenesis was unaffected. As TRH upregulated the intrafollicular production of ‘‘pituitary’’ neurohormones
(proopiomelanocortin transcription and ACTH immunoreactivity) and as agouti-signaling protein counteracted
TRH-induced HF pigmentation, these pigmentary TRH effects may be mediated in part by locally generated
melanocortins and/or by MC-1 signaling. Our study introduces TRH as a novel, potent, selective, and
evolutionarily highly conserved neuroendocrine factor controlling human pigmentation in situ. This
physiologically relevant and melanocyte sub-population-specific neuroendocrine control of human pigmenta-
tion deserves clinical exploration, e.g., for preventing or reversing hair graying.
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INTRODUCTION
Thyrotropin-releasing hormone (TRH; synonyms: thyroliberin
and thyrotropin-releasing factor) is a neurohormone that is
best known as the upstream hypothalamic neuroendocrine
stimulus that controls thyroid hormone production. TRH
reaches the anterior pituitary gland through the hypophyseal
portal system to induce the release of thyroid-stimulating
hormone by pituitary ‘‘thyrotrope’’ cells. As the most
proximal regulatory element of the hypothalamic–pituitary–
thyroid axis, TRH is initially synthesized in medial neurons of
the paraventricular nucleus of the hypothalamus as a 242
amino-acid precursor, which is proteolytically processed to
the mature TRH tripeptide (Lechan and Hollenberg, 2003;
Chiamolera and Wondisford, 2009).
However, the brain is not the only site of TRH expression
and synthesis. For example, the gastrointestinal system and
pancreatic islet cells have been reported to constitute extra-
hypothalamic sites of TRH production (Martino et al., 1978;
Leduque et al., 1989). This has greatly raised interest in the
full range of non-classical TRH functions—for example, in
‘‘cytokine-induced sickness behavior’’ (Kamath et al., 2009),
the control of energy homeostasis (not only through TRH-
controlled thyroid function but also through central effects of
TRH on feeding behavior, thermogenesis, locomotor activa-
tion, and autonomic nervous regulation; Lechan and Fekete,
2006), regulation of cardiovascular functions (Garcı´a and
Pirola, 2005), and as a multifunctional hypophysiotropic
modulator (Galas et al., 2009).
On this background, it deserves emphasis that amphib-
ian skin has long provided intriguing, yet insufficiently
followed up, pointers to ancestral functions of TRH (Jackson
and Reichlin, 1977; Vaudry et al., 1999; Vazquez-Martinez
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Although these have largely been ignored in human biology,
TRH may still have an important role in human tissue
physiology beyond the well-recognized thyrotropic function
of TRH within the hypothalamic–pituitary–thyroid axis.
Specifically, we hypothesized that TRH may exert regulatory
functions in the human pigmentary system. This hypothesis
was based on the following considerations:
Frog skin contains surprisingly high amounts of TRH
(Jackson and Reichlin, 1977; Bolaffi and Jackson, 1979;
Vaudry et al., 1999; Vazquez-Martinez et al., 2003) and skin-
derived TRH can exert hypophysiotropic functions (e.g., it
stimulates pituitary thyroid-stimulating hormone, prolactin,
and growth hormone release in adult frogs) that may extend
to other vertebrates (Tonon et al., 1980; Vaudry et al., 1999;
Galas et al., 2009; Jenks et al., 2010). TRH is also recognized
as a potent stimulator of pituitary proopiomelanocortin
(POMC) expression and a-melanocyte-stimulating hormone
(a-MSH) secretion in frogs (Vaudry et al., 1999; Jenks et al.,
2007, 2010). TRH derived from either the hypothalamus or
the skin (Jackson and Reichlin, 1977; Vaudry et al., 1999;
Galas et al., 2009) is thought to induce amphibian skin
darkening indirectly by stimulating a-MSH release by the
pituitary gland, inducing rapid skin darkening through
melanophore stimulation (Jackson and Reichlin, 1977; Tonon
et al., 1980; Vaudry et al., 1999; Vazquez-Martinez et al.,
2003; Jenks et al., 2007, 2010).
However, it is not yet known whether TRH has direct
pigmentation-modulatory effects on amphibian skin melano-
phores and/or on normal melanocytes of mammalian species
in the absence of a pituitary gland. Intriguingly, it is not only
amphibian skin that is a major source of TRH peptides
(Jackson and Reichlin, 1977; Bolaffi and Jackson, 1979;
Vaudry et al., 1999) but even human skin and its cultured
resident cell populations transcribe hypothalamic–pituitary–
thyroid axis-related genes, such as TRH, thyrotropin (TSH),
and their receptors (TRH-R, TSH-R) (Slominski et al., 2002;
Bodo´ et al., 2009; Ga´spa´r et al., 2010; Paus, 2010). TRH-
evoked a-MSH secretion in amphibians is mediated through
TRH-R3, a receptor not detected in mammals (Bidaud et al.,
2004). Isolated neonatal human epidermal keratinocytes,
dermal fibroblasts, and hair follicle (HF) papilla fibroblasts
reportedly express TRH mRNA in vitro (Slominski et al.,
2002). Most recently, we have identified normal human scalp
HFs as yet another extra-hypothalamic source of TRH
production. TRH is not only expressed constitutively by
human HFs on the gene and protein level but also stimulates
hair shaft production and HF keratinocyte proliferation in
organ-cultured human scalp HFs (Ga´spa´r et al., 2010).
Following the above leads from frog skin to potential
pigmentary activities of TRH in human skin, we have asked
whether TRH can directly alter pigmentation in human
epidermis and/or HFs in the absence of a pituitary gland.
To dissect the as yet obscure role of TRH in mammalian
pigmentation, we performed organ culture of the extremely
hormone-sensitive HF as an excellent, clinically relevant
model for unraveling non-classical functions of neuropeptide
hormones (Ito et al., 2005; Kauser et al., 2005, 2006;
van Beek et al., 2008; Bodo´ et al., 2009; Schneider et al.,
2009; Ga´spa´r et al., 2010; Ramot et al., 2010). Given the
well-documented sensitivity of human HF pigmentation
to neuroendocrine stimuli such as corticotropin-releasing
hormone and the POMC products a-MSH, ACTH, and
b-endorphin (Ito et al., 2005; Kauser et al., 2005, 2006;
Slominski et al., 2005a), we reasoned that the human HF
should be particularly well suited to reveal clinically relevant
pigmentation-modulatory action of TRH. TRH pigmentary
effects observed in organ-cultured human HFs were com-
pared with those seen in full-thickness human scalp skin
organ culture (Lu et al., 2007), to directly compare the TRH
response of normal adult human epidermal with human HF
melanocytes in situ. We focused on dissecting the impact of
TRH on the human HF pigmentary unit (HFPU), the complex
neuroendocrine regulation of which remains incompletely
understood (Slominski et al., 2004; Kauser et al., 2005, 2006;
Lu et al., 2007; Schneider et al., 2009; Paus, 2011; Tobin,
2011).
RESULTS
TRH stimulates melanin synthesis in normal human scalp
HFs in the absence of a pituitary gland
First, we asked whether TRH, which is expressed by human
scalp HFs on the gene and protein level (Ga´spa´r et al., 2010),
can stimulate the pigmentation of microdissected and organ-
cultured adult human scalp HFs. Only healthy HFs in the
active growth stage of the hair cycle (anagen VI), during
which the HF engages in maximal melanin produc-
tion (Slominski et al., 2005a; Schneider et al., 2009; Tobin,
2011), were used. After 6 days of incubation with TRH (3 nM),
qualitative and quantitative Masson–Fontana histochemistry
revealed a significantly upregulated amount of histochemi-
cally detectable melanin granules in intact anagen hair bulbs
compared with vehicle controls (Figure 1a–c).
TRH stimulates intrafollicular tyrosinase mRNA expression
and enzyme activity
The fact that this reflects the de novo synthesis of melanin
was suggested by in situ enzyme histochemistry for tyro-
sinase activity, the rate-limiting enzyme of melanogenesis
(Slominski et al., 2005a): Tyrosinase activity-associated
immunofluorescence was significantly upregulated in HFs
that had been cultured for 6 days in the presence of 30 nM and
300 nM TRH (Figure 1d–f). Moreover, compared with vehicle
controls, TRH also stimulated tyrosinase gene transcription in
situ, as demonstrated by quantitative RT-PCR from extracts of
intact human anagen HFs (Figure 1g). This shows that TRH
impacts on the enzymatic key control of melanogenesis by
stimulating both gene transcription and enzyme activity.
Thus, in apparent contrast to amphibian skin melano-
phores, which are thought to require pituitary-derived signals
for stimulation by TRH (Vaudry et al., 1999; Vazquez-
Martinez et al., 2003; Jenks et al., 2007, 2010), human HF
melanocytes in situ are sensitive to TRH even in the absence
of pituitary gland-derived melanocortins such as a-MSH. As
human hair bulb epithelium expresses TRH on the gene and
protein level in situ (Ga´spa´r et al., 2010), it is conceivable
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that keratinocyte-derived TRH has paracrine effects on
melanocytes within the human HF.
TRH stimulates melanosome formation and melanocyte
dendricity in the human HFPU
To corroborate these observations by independent, comple-
mentary pigment biological parameters, we investigated the
expression of the pre-melanosomal protein gp100 (silver/
Pmel17; essential for transition of stage I (pre-) melanosomes
to stage II melanosomes (Singh et al., 2008)). Immunodetec-
tion of this pigmentation-specific protein provides a very
sensitive tool for visualizing both melanosome transfer from
melanocytes to keratinocytes and non-pigmented (amela-
notic) melanocytes in the HF (Singh et al., 2008; Kloepper
et al., 2010). As assessed by quantitative immunohistomorpho-
metry, TRH significantly increased both the total gp100-related
immunoreactivity detectable in human anagen hair bulbs
(Figure 2a–c) and the dendrite formation of human HF
melanocytes in situ (Figure 2a, b, and d). TRH treatment also
increased slightly, but not significantly, the total number of
human anagen hair bulb melanocytes that were identifiable
in situ by gp100 immunofluorescence (data not shown).
To induce hair shaft pigmentation, mature melanosomes
are transferred through melanocyte dendrites within the
HFPU to neighboring keratinocytes of the precortical hair
matrix (Slominski et al., 2005a; Kauser et al., 2006; Singh
et al., 2008; Tobin, 2011). Therefore, the stimulation of
gp100 production and the enhancement of HF melanocyte
dendricity by TRH suggest considerably more complex and
profound modulatory activities of TRH on human HF
melanocyte biology in situ than the mere stimulation of
enzymatic melanogenesis (Slominski et al., 2005a). Thus, our
gp100 data independently confirm the above histochemical
and enzymatic pigmentation data (Figure 1) and show that
TRH actually stimulates melanin biosynthesis and melano-
some transfer to recipient keratinocytes within the precortical
hair matrix of normal human scalp HFs.
TRH also stimulates melanogenesis in isolated, cultured
human HF-derived melanocytes
Next, we asked whether TRH also stimulates pigmentation in
primary cultured human HF melanocytes isolated from the
outer root sheath of normal adult human scalp HFs; i.e., in
the absence of the normal epithelial and mesenchymal
signaling environment of HF melanocytes. As expected, these
normally amelanotic cells switched on melanin production
in vitro (Kauser et al., 2005). As shown before in situ, TRH
significantly also stimulated dendricity (Figure 2e–g), gp100
expression (Figure 3a–c), and tyrosinase activity (Figure 3d–f)
in cultured human HF melanocytes. Intriguingly, even the
proliferation of human HF melanocytes was upregulated by
TRH in vitro, as shown by quantitative Ki67/gp100 double
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Figure 1. Thyrotropin-releasing hormone (TRH) stimulates melanin synthesis, tyrosinase mRNA expression, and tyrosinase activity in human scalp hair
follicles (HFs) in situ. Histochemical staining for melanin in the hair bulb demonstrates elevated pigment production after 6 days in organ-cultured, normal
human HFs incubated with TRH, compared with the vehicle-treated control (a, b). The increase of the melanin content––measured in the reference area
(rectangles as indicated in a, b)—reached significance with 3 nM TRH (c). Red fluorescence staining represents tyrosinase enzyme activity in the pigmentary unit
of TRH-treated HFs (d, e). Quantitative analysis of the tyrosinase staining intensity demonstrates significant increase at 30 nM and 300 nM TRH (f). Significant
elevation of tyrosinase mRNA expression was observed after 300 nM TRH (g). Columns represent mean±SEM of three independent experiments (n¼ 15–18 HFs
per TRH concentration per each experiment), *Po0.05 and **Po0.01 versus vehicle (TRH 0 nM; bar¼50 mm). DP, dermal papilla; HM, hair matrix.
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immunofluorescence (Figure 3g–i). These TRH-induced
effects were seen even in cultured human HF melanocytes
not showing TRH-R immunoreactivity (data not shown);
indeed, the latter reportedly do not express TRH-R mRNA
(Slominski et al., 2002).
TRH does not stimulate human epidermal melanogenesis in situ
We asked whether TRH is a general pigmentation stimulator
in human skin, or whether this effect is specific to the HF.
As shown in Figure 4a, TRH did not significantly upregulate
the histochemically determined melanin content of organ-
cultured human epidermis. Moreover, TRH failed to signi-
ficantly upregulate epidermal gp100 immunoreactivity and
tyrosinase activity in situ (Figure 4b and c). Thus, under
physiological conditions, TRH selectively stimulates human
HF melanogenesis, but not intraepidermal melanogenesis.
Interestingly, preliminary observations with adult frog skin
organ culture in our laboratory suggest that high doses of
TRH can stimulate melanosome dispersion in intracutaneous
Xenopus tropicalis melanophores in situ in the absence of a
pituitary gland (D Pattwell and R Paus, unpublished observa-
tion). These frog skin organ-culture observations suggest that,
contrary to conventional wisdom (Jackson and Reichlin,
1977; Vaudry et al., 1999), even in amphibian skin TRH can
exert direct pituitary gland-independent pigmentation-stimu-
latory effects. Although these intracutaneous pigmentation-
stimulatory effects of TRH appear to have been lost in human
epidermal melanocytes in situ, we demonstrate here that they
have been preserved in the human HFPU. Moreover, this
underscores the validity of the concept that epidermal and
hair melanocytes represent phenotypically and functionally
rather distinct sub-populations, which underlie differential
controls (Slominski et al., 2004; Plonka et al., 2009; van
Raamsdonk et al., 2009; Tobin, 2011).
The HFPU does not seem to express TRH-R protein
A major challenge remains to identify the mechanism(s) of
action by which TRH may exert its complex pigmentary-
stimulatory function on human HF melanocytes in situ and
in vitro. We had already shown that TRH-R mRNA is
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Figure 2. Thyrotropin-releasing hormone (TRH) stimulates melanosome formation and dendricity in human melanocytes in situ and in vitro.
TRH administration in vitro (3–300 nM). TRH significantly increased the pre-melanosome marker gp100 expression (red) in human anagen hair bulbs
(a, b, c) and the dendrite formation of human hair follicle (HF) melanocytes in situ (d). TRH administration in vitro (15–300 nM) significantly stimulated the
number of gp100þ melanocytes (e, f, g). Columns represent mean±SEM of three independent experiments (n¼15–18 HFs per TRH concentration per
each experiment), *Po0.05, **Po0.01, and ***Po0.001 versus vehicle (TRH 0 nM; bar¼ 50mm). DP, dermal papilla; HM, hair matrix; HPM, hair follicle
pigmentary unit; IR, immunoreactivity.
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detectable in human HF extracts, although the expression of
TRH-R protein in situ appears largely limited to the inner root
sheath of the HF (Ga´spa´r et al., 2010). Also, isolated human
HF melanocytes do not express TRH-R mRNA in vitro
(Slominski et al., 2002). This made it difficult to understand
how TRH exerts its HF pigmentary effects on the HFPU.
Therefore, we double checked this earlier observation
with a highly sensitive light-microscopic immunohistology
technique (Envision-ABC), so as to more accurately define the
anatomical localization of the TRH-R protein expression
pattern, using optimal positive and negative immunoreac-
tivity controls. However, this method independently con-
firmed the TRH-R negativity of the human HFPU (Supplemen-
tary Figure S1 online). If melanogenically active human HF
melanocytes express any functional TRH-R protein at all
in situ, this was below our limit of detection. Even isolated,
cultured human HF melanocytes from the outer root sheath
showed no evidence of specific TRH-R immunoreactivity (data
not shown). This suggests that the intrafollicular pigmentary
effects of TRH are unlikely to be mediated by direct stimulation
of TRH-Rs expressed by melanocytes of the human HFPU.
POMC-dependent signaling may mediate the pigmentary
effects of TRH
Therefore, we next asked whether an indirect mode of action
may explain the profound pigmentary effects of TRH. Our HF
organ culture data had clearly shown that hypothalamus-
and/or pituitary gland-derived signals are dispensable for the
observed pigmentary effects of TRH. However, as human
scalp HFs express as an astounding variety of ‘‘hypo-
thalamic’’ and ‘‘pituitary’’ neurohormones (Slominski et al.,
2000, 2002; Kauser et al., 2004, 2005, 2006; Ito et al., 2005;
Paus, 2010, 2011), TRH may well have upregulated intra-
follicular POMC expression and a-MSH and/or ACTH
production from this prohormone. In fact, the epithelium of
human scalp HFs has established a fully functional peripheral
equivalent system of the hypothalamic–pituitary–adrenal axis
(Ito et al., 2005), and human HFs are now appreciated to
prominently transcribe and translate POMC, from which
ACTH and a-MSH are processed (Slominski et al., 2000; Ito
et al., 2005; Kauser et al., 2005, 2006).
Therefore, we tested by RT-PCR whether POMC mRNA
steady-state levels after TRH treatment were altered. After 8 h
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of incubating organ-cultured HFs with 15 nM TRH, intrafolli-
cular POMC transcript levels were significantly increased
(Figure 5a). On the protein level, quantitative immuno-
histomorphometry revealed that TRH significantly upregu-
lated the intrafollicular immunoreactivity for ACTH in situ
(Figure 5b; Supplementary Figure S2a online). Even though
the immunoreactivity for a-MSH also showed a slight
increase after TRH stimulation in the proximal epithelium
of some HFs (as illustrated, e.g., in Supplementary Figure S2b
online), overall this was not statistically significant (Supple-
mentary Figure S2c online). It is conceivable that intra-
follicularly generated TRH (Ga´spa´r et al., 2010) upregulates
intrafollicular POMC expression and its processing to
melanotropic, POMC-derived peptides (such as ACTH), and
thereby stimulates human HF pigmentation indirectly.
TRH may stimulate HF pigmentation by binding to the
melanocortin-1 receptor
Given that both ACTH and a-MSH stimulate human HF
melanocytes and intrafollicular melanogenesis by binding to
the melanocortin-1 receptor (MC-1R), we focused next on
MC-1R. MC-1R is not only prominently expressed in the
human anagen hair bulb (Slominski et al., 2005a, b; Kauser
et al., 2006; Tobin, 2011), but TRH can also use this receptor
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as an alternative mode of signaling (Schio¨th et al., 1999). As
highly selective TRH-R antagonists are currently not avail-
able, we resorted to administering TRH (3 or 15 nM) in the
presence of an excess amount of agouti-signaling protein
(ASP; 100 nM), a recognized MC-1R antagonist (Lu et al.,
1994; Ollmann et al., 1998).
Coadministration of TRH with ASP reduced both the
melanin content and the tyrosinase enzyme activity in situ to
the level of vehicle-treated control HFs or even below this level
(data not shown). These preliminary results suggest that the
stimulatory effects of TRH on human HF pigmentation could
indeed be mediated, at least in part, by binding to the MC-1R.
This would also resolve the quandary how TRH can stimulate
apparently TRH-R-negative human HF melanocytes in situ
and in vitro, as both prominently express MC-1R (Kauser et al.,
2005, 2006; Slominski et al., 2005a, b; Tobin, 2011). In
addition, this would explain the ability of follicular melano-
cytes of POMC knockout mice to still produce eumelanin even
in the absence of POMC products (Slominski et al., 2005b).
TRH stimulates intrafollicular MITF protein expression
Finally, we assessed the impact of TRH on microphthalmia-
associated transcription factor (MITF), the ‘‘master regulator
of pigmentation’’ (Nishimura et al., 2005; Vachtenheim and
Borovansky`, 2010). This transcription factor is not only
activated by MC-1R stimulation (Rouzaud et al., 2006; Chou
et al., 2010) but also controls more than 25 genes in pigment
cells that affect melanogenesis, melanocyte development,
proliferation, and survival, as well as intrafollicular melano-
cyte stem cell functions (Nishimura et al., 2005). Therefore,
we asked whether TRH upregulated the intrafollicular expres-
sion of MITF protein. As seen in Figure 5c–e, immuno-
reactivity for MITF hair bulbs was significantly increased in
TRH-treated HFs compared with vehicle controls. In addi-
tion, the percentage of MITF-positive cells increased under
TRH administration (Figure 5c). Given that a MITF-dependent
decline in the number of human HF melanocyte stem cells
is considered by many investigators to be a chief cause
of hair graying (Nishimura et al., 2005; Tobin, 2011), it is
particularly intriguing to note that TRH can upregulate
intrafollicular MITF expression.
DISCUSSION
Our study presents the first evidence that TRH (1) exerts any
effects on normal mammalian melanocytes in situ, (2)
stimulates melanin production in appendages of normal
adult human skin, (3) stimulates human HF, but not human
epidermal melanocytes, and (4) that these pigmentation-
stimulatory effects are independent of the pituitary gland .
Moreover, our study reveals a novel and apparently HF-
specific and evolutionarily highly conserved neuroendocrine
control system of human pigmentation (Paus, 2011) that may
date back at least to the role that these controls attained
already in amphibian skin biology.
This newly identified, physiologically relevant, and melano-
cyte sub-population-specific control of human pigmentation
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Figure 5. Thyrotropin-releasing hormone (TRH) stimulates proopiomelanocortin (POMC ) mRNA expression and ACTH and micropathalmia-associated
transcription factor (MITF) immunoreactivity in human scalp hair follicles (HFs) in situ. TRH 15 nM significantly upregulated POMC mRNA expression (a), and
TRH 3–30 nM upregulated the ACTH immunoreactivity in organ-cultured human HFs in situ (b). TRH also significantly increased intrafollicular MITF protein
expression (c). Green fluorescence shows the immunoreactivity for MITF in TRH-treated hair bulbs (d, e). Columns represent mean±SEM of three
independent experiments (n¼ 15–18 HFs per TRH concentration per each experiment), *Po0.05 and ***Po0.001 versus vehicle (TRH 0 nM; bar¼ 50 mm).
BM, basal membrane; DP, dermal papilla; HM, hair matrix.
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deserves full exploration not only in melanocyte biology but
also as a potential target to prevent or reverse hair graying
(Tobin and Paus, 2001; Tobin 2011). As TRH is an unusually
stable tripeptide, it is conceivable that high intrafollicular
TRH doses could be achieved after topical application,
e.g., by HF-targeting liposomes (Ciotti and Weiner, 2002;
Chourasia and Jain, 2009). This could help to circumvent
an undesired rise in systemic TRH levels that may induce
excessive thyroid hormone secretion.
The proposed key role of MITF in graying of human
hair (Nishimura et al., 2005) and the stimulatory effect of
TRH that we have observed here on the intrafollicular
expression of this master regulator of pigmentation and
of HF melanocyte stem cells (Nishimura et al., 2005;
Vachtenheim and Borovansky`, 2010; Tobin, 2011) encou-
rage one to explore TRH and/or TRH-mimetic peptides as
antigraying agents. The fact that TRH is already regularly used
in clinical endocrinology (TRH stimulation test in thyroid
medicine) should greatly facilitate the clinical testing of this
tripeptide as a new candidate agent for halting or reversing
human hair graying.
Although the full range of mechanisms through which
TRH exerts its complex stimulatory effects on human HF
pigmentation remains to be definitively clarified, our
currently available data suggest that TRH stimulates intra-
follicular POMC expression by HF keratinocytes. This then
primarily upregulates the intrafollicular production of ACTH,
which binds to MC-1R and MC-2R receptors in human HFs
(Ito et al., 2005; Kauser et al., 2005). This mechanistic
scenario is supported by clinical evidence: Intravenous
administration of TRH to pregnant women, or to a subgroup
of patients with Cushing’s disease, reportedly induces
increased serum ACTH levels (Pieters et al., 1982a, b). TRH
may exploit the intrafollicular production of classical
‘‘pituitary’’ melanotropic hormones to stimulate HF pigmen-
tation indirectly. Moreover, TRH appears to non-classically
stimulate intrafollicular MC1-R-mediated signaling.
Our data suggest that MC-1R is the key receptor in
transducing the pigmentary effects of TRH. This is supported
by several lines of argumentation: (1) The HFPU does not
express immunohistochemically detectable TRH-Rs; (2) cul-
tured HF melanocytes do not express detectable TRH-R
protein or transcripts, but functional MC-1R (Abdel-Malek
et al., 1999; Slominski et al., 2002; Kadekaro et al., 2003;
Kauser et al., 2005), yet respond to TRH stimulation; (3) TRH
can non-classically signal via the human MC1-R (Pieters et al.,
1982a); (4) the stimulatory effects of TRH on human hair
pigmentation can be partially antagonized by the selective
competitive MC-1R antagonist, ASP; (5) as proposed before,
the unexpected production of eumelanin in POMC knockout
mice on a C57BL/6 background indicates the existence of an
alternative ligand for MC1-R (Slominski et al., 2002); our
findings raise the possibility that (e.g., intrafollicularly
generated) TRH could be this alternative ligand.
However, additional potential mechanisms of action
should be considered and explored in future studies. For
example, TRH could also stimulate intrafollicular b-endor-
phin processing, as this POMC product can stimulate human
HF pigmentation (Kauser et al., 2004). Even unprocessed
POMC itself may stimulate melanin production by human
melanocytes in vitro (Rousseau et al., 2007). As we show here
that TRH upregulates intrafollicular POMC transcription, this
additional mechanism of action deserves careful considera-
tion. In theory, even receptor-independent signaling events
might contribute to the pigmentary effects of this small
tripeptide neurohormone in situ and in vitro. However, our
finding that ASP partially antagonizes TRH pigmentary effects
argues in favor of a predominantly MC1-R-dependent
mechanism.
The current study strongly encourages one to system-
atically follow up available pointers to evolutionarily ancient
controls of pigmentation that may still be conserved in
human skin. In this context, amphibian skin neuroendocri-
nology (Jackson and Reichlin, 1977; Bolaffi and Jackson,
1979; Vaudry et al., 1999; Vazquez-Martinez et al., 2003;
Jenks et al., 2007, 2010; Slominski 2007; Slominski et al.,
2008; Galas et al., 2009) promises valuable lessons for the
mammalian system that may bear direct relevance for the
management of human pigmentary disorders. We show that
human HF organ culture and the highly hormone-sensitive
HF melanocyte populations provide excellent discovery tools
for elucidating ancestral, evolutionarily conserved, and
clinically relevant non-classical neurohormone functions in
human biology.
Our study also underscores the value of dissecting the
physiological controls of human melanocyte biology in
organ culture, rather than in non-physiological cell culture
systems where melanocytes operate in the absence of crucial
epithelial and mesenchymal cues. As human HF organ culture
facilitates the study of human melanocyte functions within
their natural tissue habitat and under full preservation of
normal keratinocyte–fibroblast–melanocyte interactions (Slo-
minski et al., 2005a; Plonka et al., 2009), it offers an
instructive, accessible, and clinically relevant test system for
characterizing the neuroendocrine controls of melanogenesis
and human melanocyte biology in situ (Ito et al., 2005; Kauser
et al., 2005, 2006; Schneider et al., 2009; Paus, 2011).
MATERIALS AND METHODS
HF organ culture
The study adhered to the Declaration of Helsinki Principles, was
approved by the Institutional Research Ethics Committee of the
University of Lu¨beck, and patients gave their written informed
consent. Anagen VI HFs were microdissected from normal human
scalp skin obtained from three healthy adult females undergoing
routine face-lift cosmetic surgery (Kloepper et al., 2010). Serum-free
HF organ culture was performed in the presence of vehicle, TRH
(3–300 nM; Bachem, St Helens, UK), and/or ASP (100 nM; Phoenix
Pharmaceuticals, Burlingame, CA; see Supplementary Materials and
Methods online).
Human scalp skin organ culture
Full-thickness human scalp skin organ culture was performed for
6 days under serum-free conditions in the presence or absence of
3–300 nM TRH as described before (Lu et al., 2007; see Supplemen-
tary Materials and Methods online).
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Human HF melanocyte culture
The isolation and culture of melanocytes from human anagen VI
scalp HFs can be found in the Supplementary Materials and Methods
online.
Quantitative melanin histomorphometry
Masson–Fontana histochemistry was used to visualize the melanin
content in cryosections (demarcated as black dots). Melanin staining
intensity was analyzed in precisely defined, selected reference
areas of the HFPU by using the ImageJ software (http://rsbweb.nih.
gov/ij/download.html; see Supplementary Materials and Methods
online).
Immunohistochemistry or immunofluorescence
ACTH, gp100, MITF, a-MSH, and TRH-R immunohistochemistry
was performed on 7 mm cryostat sections of HFs fixed in acetone at
20 1C (10 min). Quantitative immunohistomorphometry in pre-
cisely defined reference areas was performed by using Image J
software (see Supplementary Materials and Methods online).
Immunocytochemical analysis of cultured HF melanocytes
Human HF melanocytes grown on coverslips were incubated with
Nki/beteb (Monosan, Uden, The Netherlands; 1:30 in phosphate-
buffered saline), anti-Ki-67 (1:100 in phosphate-buffered saline,
Zymed Laboratories, South San Francisco, CA), or a polyclonal
rabbit anti-TRH-receptor antibody, which recognizes the human
TRH receptor (homolog to murine TRH-R1; 1:100 in TBSþ 2% NGS;
Acris, Hiddenhausen, Germany) overnight at 4 1C (see Supplemen-
tary Materials and Methods online).
In situ tyrosinase enzyme activity
Tyrosinase enzyme activity was measured by tyramide-based
tyrosinase immunohistochemistry (Han et al., 2002). The fluores-
cence staining intensity, which reflects tyrosinase activity in situ, was
quantified with ImageJ software. This assay was also used to measure
tyrosinase activity of cultured human outer root sheath melanocytes.
Quantitative PCR for tyrosinase and POMC mRNA
Normal human scalp skin HFs were microdissected and cultured in
the absence or presence of TRH (15–300 nM) for 8 h. Total RNA was
isolated from 20 HFs per experimental group (see Supplementary
Materials and Methods online).
Statistical analysis
Student’s t-test for unpaired samples was calculated with GraphPad
Prism 4.00 program (GraphPad Software, San Diego, CA).
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